Free Trial

Biogen (BIIB) Insider Trading & Ownership

Biogen logo
$140.64 +3.56 (+2.60%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$140.62 -0.02 (-0.02%)
As of 02/21/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Biogen (NASDAQ:BIIB) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.16%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$165,798.45
Get BIIB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Biogen stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BIIB Insider Buying and Selling by Quarter

Biogen Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/3/2024Priya SinghalInsiderSell431$204.22$88,018.82  
4/2/2024Priya SinghalInsiderSell93$213.09$19,817.37  
2/22/2024Priya SinghalInsiderSell262$221.23$57,962.26  
(Data available from 1/1/2013 forward)

BIIB Insider Trading Activity - Frequently Asked Questions

The list of insiders at Biogen includes Eric K Rowinsky, Ginger Gregory, Priya Singhal, and Susan H Alexander. Learn more on insiders at BIIB.

0.16% of Biogen stock is owned by insiders. Learn more on BIIB's insider holdings.

The following insider purchased BIIB shares in the last 24 months: Eric K Rowinsky ($101,255.70).

Insiders have purchased a total of 455 BIIB shares in the last 24 months for a total of $101,255.70 bought.

The following insiders have sold BIIB shares in the last 24 months: Ginger Gregory ($804,300.00), and Priya Singhal ($634,976.81).

Insiders have sold a total of 5,275 Biogen shares in the last 24 months for a total of $1,439,276.81 sold.

Biogen Key Executives

  • Mr. Christopher A. Viehbacher (Age 63)
    President, CEO & Director
    Compensation: $4.07M
  • Mr. Michael R. McDonnell CPA (Age 60)
    Executive VP & CFO
    Compensation: $2.21M
  • Ms. Nicole Murphy (Age 51)
    Head of Pharmaceutical Operations & Technology
    Compensation: $1.45M
  • Ms. Susan H. Alexander Esq.Ms. Susan H. Alexander Esq. (Age 67)
    Executive VP & Chief Legal Officer
    Compensation: $1.95M
  • Mr. Rachid Izzar (Age 49)
    Head of Global Product Strategy & Commercialization
    Compensation: $1.27M
  • Ms. Robin C. Kramer (Age 58)
    Senior VP & Chief Accounting Officer
  • Mr. Charles E. Triano
    Senior VP & Head of Investor Relations
  • Ms. Natacha Gassenbach
    Chief Communication Officer & Head of Corporate Affairs
  • Mr. Adam Keeney Ph.D. (Age 47)
    Executive VP & Head of Corporate Development
  • Dr. Ginger Gregory Ph.D. (Age 56)
    Executive VP & Chief Human Resources Officer
    Compensation: $1.59M


This page (NASDAQ:BIIB) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners